Therapeutic extended reality platform XRHealth announced it acquired cognitive training VR platform NeuroReality and its assets, including its main product, Koji’s Quest.Boston-based XRHealth offers a catalog of immersive medical extended reality (XR) experiences focused…
Continue Reading
DarioHealth, a digital chronic condition management platform, announced a collaboration with an unnamed pharma company that will leverage DarioConnect (formerly Twill Care) to advance its direct-to-consumer initiatives using Dario’s engagement and navigation technologies.The aim…
Continue Reading
Digital decision support and remote patient monitoring may improve outcomes and efficiency, but rarely scale beyond a single institution. Over the last 5 years, the platform Timely Interventions for Diabetes Excellence (TIDE) has been…
Continue Reading
Digital Healthcare company WELL Health Technologies Corp. entered into definitive agreements to acquire the clinical assets of Jack Nathan Medical Corp., which includes a network of 16 owned and operated primary care clinics across…
Continue Reading
Recovery.com, a marketplace-style platform for patients and mental health professionals, has garnered $5 million in funding from Jason Krantz, the founder and executive chairman of data analytics company Definitive Healthcare.The recent funding brings Krantz’s…
Continue Reading
Concerns have been raised that the government’s NHS digital and data plans could exacerbate health inequalities for older adults who do not have access to technology.
In October 2024, the Department of Health and Social…
Dr Anas Nader, Patchwork Health chief executive (left) and Jim McLaughlin, L2P chief executive (right) (Credit: Isabelle Lemettre)
Patchwork Health has announced the acquisition of medical appraisal software and job planning software firm L2P…
Continue Reading
Background: As the most malignant type of cancer in the female reproductive system, ovarian cancer (OC) has become the second leading cause of death among Chinese women. Chemotherapy is the main treatment for OC…
Continue Reading
Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat neovascular age-related macular degeneration (nAMD) dubbed HG202, developed…
Continue Reading
What You Should Know:
– Volpara Health, a global leader in cancer detection software, has been awarded a significant contract with the U.S. Defense Health Agency (DHA) valued at $7.3M over five years.
– The contract…
Continue Reading
